欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (9): 1153-1164.doi: 10.12092/j.issn.1009-2501.2025.09.001

• 基础研究 • 上一篇    下一篇

健脾化痰方治疗脾虚痰湿证多囊卵巢综合征患者调节性T细胞和Th17细胞的影响及模型化评价

戴月1,贺冰1,杨思婕2,余曦明2,杨正望3,李岚1   

  1. 1湖南中医药大学第二附属医院妇科,长沙  410005,湖南;2湖南中医药大学,长沙  410208,湖南; 3湖南中医药大学第一附属医院妇科,长沙  410007,湖南
  • 收稿日期:2025-02-24 修回日期:2025-06-20 出版日期:2025-09-26 发布日期:2025-09-09
  • 通讯作者: 李岚,女,硕士研究生,副主任医师,研究方向:月经病的中西结合诊疗。 E-mail: llgyptyqt@163.com
  • 作者简介:戴月,女,硕士研究生,主治医师,研究方向:子宫内膜异位症及女性不孕的中西医结合诊疗。 E-mail: daiyue8880@163cn.email
  • 基金资助:
    湖南省自然科学基金医卫联合项目(2024JJ9446)

Effects and model evaluation of Jianpi Huatan formula on regulatory T cells and Th17 cells in polycystic ovary syndrome patients with spleen deficiency phlegm dampness syndrome

DAI Yue1, HE Bing1, YANG Sijie2, YU Ximing2, YANG Zhengwang3, LI Lan1    

  1. 1 Department of Gynecology, the Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410005, Hunan, China; 2 Hunan University of Traditional Chinese Medicine, Changsha 410208, Hunan, China; 3 Department of Gynecology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410007, Hunan, China
  • Received:2025-02-24 Revised:2025-06-20 Online:2025-09-26 Published:2025-09-09

摘要:

目的:探讨健脾化痰方治疗脾虚痰湿证多囊卵巢综合征(PCOS)患者调节性T细胞(Treg)和辅助性T细胞17(Th17)细胞的影响,并进行模型化评价。方法:选取2023年1月至2024年10月本院收治的92例脾虚痰湿证PCOS患者作为研究对象,采用倾向性评分匹配(PSM)法按照1:1匹配后,两组各为46例。对照组给予常规治疗,观察组在对照组的基础上给予健脾化痰方治疗。比较分析两组临床资料差异;比较两组患者治疗前后性激素、糖代谢及中医证候积分变化,并重点比较两组患者治疗前后Treg和Th17细胞变化;并采用广义估计方程(GEE)模型分析其改善情况;采用多元线性回归分析其与中医证候积分的关联分析;采用非线性混合效应模型建立健脾化痰方治疗脾虚痰湿证PCOS的时间效应模型;通过拟合优度评价最终模型的拟合效果;采用Bootstrap检验评价模型参数的稳定性;采用可视化预测检验评估模型的预测性能。基于最终模型模拟各基线下中医症状积分的典型时间效应曲线。结果:两组患者治疗后观察组总有效率显著高于对照组(χ2 =4.842,P=0.028);与治疗前相比,两组患者治疗后1月、3月后总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、雄激素(T)、黄体生成素(LH)、促卵泡生成素(follicle stimulating hormone,FSH)、抗缪勒管激素(AMH)、空腹血糖(FPG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、中医证候积分明显降低,雌二醇(E2)、高密度脂蛋白胆固醇(HDL-C)明显升高,且观察组改善幅度明显大于对照组(P<0.05);重复测量方差分析结果显示两组患者Treg、Th17、Treg/Th17时间效应、组间效应和交互效均存在统计学差异(P<0.05)。GEE分析结果显示观察组Treg、Th17、Treg/Th17的改善情况均优于对照组(P<0.05);多元线性回归分析结果显示TC、TG、LDL-C、T、LH、FSH、AMH、FPG、FINS、HOMA-IR、Th17与中医证候积分呈显著正相关,HDL-C、E2、Treg、Treg/Th17与中医证候积分呈显著负相关(P<0.05);中医症状积分较基线的下降值随着时间逐渐增加,最终达到药效平台,符合经典的Emax模型。逐步筛选协变量后,发现中医症状积分基线值对药效参数Emax有显著影响,最终模型为:Emax,i=15.42+1.21×(Baselinei-24.41)。拟合优度结果显示,最终模型对实测数据的拟合效果较好。Bootstrap检验获得的模型参数与原模型非常吻合,提示模型参数估算稳健。可视化预测检验结果显示,模型具有较好的预测效能。典型药效时间曲线显示,中医症状积分基线值越高,积分降低幅度越大,治疗3月时,各基线下中医症状积分基本降低至10分以下。结论:健脾化痰方可以有效改善治疗脾虚痰湿证PCOS患者Treg、Th17水平,且疗效较好,值得临床应用。

关键词: 多囊卵巢综合征, 脾虚痰湿证, 健脾化痰方, 调节性T细胞, Th17, 评价

Abstract:

AIM: To explore the effects of Jianpi Huatan formula on regulating T cells and helper T cells 17 (Th17) cells in patients with polycystic ovary syndrome (PCOS) due to spleen deficiency and phlegm dampness syndrome, and conduct a model evaluation. METHODS: Ninety-two patients with spleen deficiency phlegm dampness syndrome (PCOS) admitted to our hospital from January 2023 to October 2024 were selected as the research subjects. Propensity score matching (PSM) method was used to match them in a 1:1 ratio, with 46 patients in each group. The control group received conventional treatment, while the observation group received treatment with Jianpi Huatan formula on the basis of the control group. Compared and analyze the differences in clinical data and laboratory indicators between two groups; Compared the changes of sex hormone, glucose metabolism and TCM syndrome score before and after treatment in the two groups, and focused on the changes of regulatory T cells (Treg) and Th17 cells in the two groups before and after treatment; And used the Generalized Estimation Equation (GEE) model to analyze its improvement. Multiple linear regression analysis was used to examine its correlation with the score of traditional Chinese medicine syndrome. A time effect model of Jianpi Huatan formula for treating PCOS with spleen deficiency and phlegm dampness syndrome was established using a nonlinear mixed effects model. The fitting effect of the final model was evaluated through the goodness of fit. Bootstrap was used to test and evaluate the stability of model parameters. Visual prediction testing was used to evaluate the predictive performance of the model. Typical time effect curves of traditional Chinese medicine symptom scores was simulated based on the final model for each baseline. RESULTS: After treatment, the total effective rate of the observation group was significantly higher than that of the control group (χ2=4.842, P=0.028); Compared with before treatment, after 1months and 3 months of treatment, TC, TG, LDL-C, T, LH, FSH, AMH, FPG, FINS, HOMA-IR, the score of traditional Chinese medicine syndrome were significantly reduced, while E2 and HDL-C were significantly increased, and the improvement in the observation group was significantly greater than that in the control group (P<0.05);The results of repeated measures ANOVA showed significant differencesin the time effects, inter group effects, and interaction effects of Treg, Th17, and Treg/Th17 between the two groups of patients (P<0.05) . The GEE analysis results showed that the improvement of Treg, Th17, and Treg/Th17 in the observation group were better than that in the control group (P<0.05);The results of multiple linear regression analysis showed that the levels of TC,TG, LDL-C,T, LH, FSH, AMH, FPG, FINS, HOMA-IR, Th17 were significantly positively correlated with TCM syndrome score, while the levels of E2, HDL-C, Treg, and Treg/Th17 were significantly negatively correlated with TCM syndrome score (P<0.05); The decrease in traditional Chinese medicine symptom score compared to baseline gradually increases over time, eventually reaching the pharmacological platform, which was consistent with the classic Emax model. After gradually screening covariates, it was found that the baseline value of traditional Chinese medicine symptom score had a significant impact on the efficacy parameter Emax. The final model was Emax, i=15.42+1.21×(Baselinei-24.41). The goodness of fit results showed that the final model had a good fitting effect on the measured data. The model parameters obtained from Bootstrap testing were very consistent with the original model, indicated that the model parameter estimation was robust. The visual prediction test results showed that the model had good predictive performance. The typical efficacy time curve showed that the higher the baseline value of TCM symptom score, the greater the decrease in score. At 3 months of treatment, the TCM symptom score at each baseline basically decreased to below 10 points. CONCLUSION: The formula for strengthening the spleen and resolving phlegm can effectively improve the levels of Treg and Th17 in PCOS patients with spleen deficiency and phlegm dampness syndrome, and has good therapeutic effects, which is worthy of clinical application.

Key words: polycystic ovary syndrome, spleen deficiency phlegm dampness syndrome, Jianpi huatan formula, regulatory T cells, Th17, evaluate

中图分类号: